← SynDRA
AVASIMIBE
SynDRA canonical compound SYN0003885 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ABCB1 | CES1 | SOAT1 |
|---|
| Mechanism of action | ACAT inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ACAT inhibitor
- CES1 INHIBITOR
Drug classes
- Cytochrome P-450 CYP3A Inducers
Cross-references
Synonyms
- Avasimiba
- CI-1011
- CI 1011
- Avasimibe(CI-1011)
- UNII-28LQ20T5RC
- Avasimibe (CI-1011)
- PD 148515
- CHEMBL101309
- 28LQ20T5RC
- 2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)acetyl)sulfamate
- 2,6-diisopropylphenyl 2-(2,4,6-triisopropylphenyl)acetylsulfamate
- 2,6-Diisopropylphenyl ((2,4,6-triisopropylphenyl)acetyl)sulfamate
- 2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)-acetyl)sulfamate
- ((2,4,6-Tris(1-methylethyl)phenyl)acetyl)sulfamic acid 2,6-bis(1-methylethyl)phenyl ester
- avasimibum
- RefChem:560377
- DTXCID7090608
- MFCD00934956
- Avasimibe [USAN]
- SMR002530075
- C29H43NO4S
- Avasimibe [USAN:INN]
- Avasimibe,CI-1011
- AVASIMIBE [INN]
- AVASIMIBE [MI]
- Avasimibe (USAN/INN)
- AVASIMIBE [WHO-DD]
- Avasimibe (CI-1011)?
- BIDD:PXR0029
- SCHEMBL15876
- MLS006010422
- MLS006010991
- orb1305068
- Avasimibe, >=98% (HPLC)
- CHEBI:177719
- GLXC-05001
- HMS3655H08
- HMS3866C13
Look up AVASIMIBE in the interactive SynDRA portal →